CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase III Open-Label Study of Immunogenicity, Safety, and Tolerability of 2 Doses of VAQTA™ (Formalin, Inactivated, Alum-Adjuvanted Hepatitis A Vaccine) in Healthy Children 12 to 23 Months of Age

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00835380
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:36.643615+00:00
Published At: 2010-01-11T00:00:00+00:00
Record Updated At: 2017-04-13
Results Posted At: 2010-01-11
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hepatitis A Virus Infection"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-04-13"
protocolSection.identificationModule.nctId: "NCT00835380"
protocolSection.identificationModule.officialTitle: "A Phase III Open-Label Study of Immunogenicity, Safety, and Tolerability of 2 Doses of VAQTA\u2122 (Formalin, Inactivated, Alum-Adjuvanted Hepatitis A Vaccine) in Healthy Children 12 to 23 Months of Age"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2010-01-11"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.